𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dividing cells in bone marrow and spleen incorporate bromodeoxyuridine with high efficiency

✍ Scribed by Birgit Schittek; Klaus Rajewsky; Irmgard Förster


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
388 KB
Volume
21
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Effect of bnu treatment on leukaemogenes
✍ H. Shisa; E. Legrand; R. Daculsi 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 French ⚖ 598 KB

## Abstract The leukaemogenic effect of N‐butyl‐N‐nitrosourea (BNU) was studied in normal and thymectomized AKR mice which were lethally irradiated and restored with either bone‐marrow (BM) or spleen cells from (AKR × AKR/T1ALD)F~1~ donors. In some instances T1ALD thymic cells were added to the res

Effect of combination treatment with cyc
✍ S. Vadlamudi; M. Padarathsingh; E. Bonmassar; A. Goldin 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 French ⚖ 496 KB

## Abstract Generalized leukemia was observed on day 3 following intra‐peritoneal inoculation of leukemic (L1210) ascites cells in CDF~1~ mice. On day 3 after tumor implantation, residual viable leukemic cells were detected in the peritoneal cavities and spleens of leukemic mice 6 h following treat

Organ interactions in the regulation of
✍ Martin J. Cline; Carol Le Fevre; David W. Golde 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## Abstract Hematopoietic cell differentiation is influenced by organ‐dependent microenvironmental factors as well as humoral regulators. A technique is described for examining certain aspects of the hemopoietic inductive microenvironment in vitro. Suspension and agar cultures of mouse bone marrow

Monitoring of disseminated tumor cells i
✍ Vilde Drageset; Jahn M. Nesland; Bjorn Erikstein; Eva Skovlund; Hilde Sommer; Gu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB 👁 1 views

## Abstract The present study aimed to investigate the clinical relevance of disseminated tumor cells (DTC) in breast cancer patients before and after high‐dose adjuvant chemotherapy with or without progenitor stem‐cell support. One hundred and eighteen high‐risk stage II breast cancer patients ent